139 related articles for article (PubMed ID: 35306171)
1. Equine immunoglobulin fragment F(ab')
Gupta D; Ahmed F; Tandel D; Parthasarathy H; Vedagiri D; Sah V; Krishna Mohan B; Khan RA; Kondiparthi C; Savari P; Jain S; Reddy S; Kumar JM; Khan N; Harshan KH
Clin Immunol; 2022 Apr; 237():108981. PubMed ID: 35306171
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection.
Li E; Han Q; Bi J; Wei S; Wang S; Zhang Y; Liu J; Feng N; Wang T; Wu J; Yang S; Zhao Y; Liu B; Yan F; Xia X
Front Immunol; 2023; 14():1066730. PubMed ID: 36875106
[TBL] [Abstract][Full Text] [Related]
3. PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab')
Xu M; Bi J; Liang B; Wang X; Mo R; Feng N; Yan F; Wang T; Yang S; Zhao Y; Xia X
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834803
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin fragment F(ab')
Pan X; Zhou P; Fan T; Wu Y; Zhang J; Shi X; Shang W; Fang L; Jiang X; Shi J; Sun Y; Zhao S; Gong R; Chen Z; Xiao G
Antiviral Res; 2020 Oct; 182():104868. PubMed ID: 32659292
[TBL] [Abstract][Full Text] [Related]
5. Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
Wang X; Ni B; Du X; Zhao G; Gao W; Shi X; Zhang S; Zhang L; Wang D; Luo D; Xing L; Jiang H; Li W; Jiang M; Mao L; He Y; Xiao Y; Wu Y
Antivir Ther; 2005; 10(5):681-90. PubMed ID: 16152762
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal F(ab')
Cunha LER; Stolet AA; Strauch MA; Pereira VAR; Dumard CH; Gomes AMO; Monteiro FL; Higa LM; Souza PNC; Fonseca JG; Pontes FE; Meirelles LGR; Albuquerque JWM; Sacramento CQ; Fintelman-Rodrigues N; Lima TM; Alvim RGF; Marsili FF; Caldeira MM; Zingali RB; de Oliveira GAP; Souza TML; Silva AS; Muller R; Rodrigues DDRF; Jesus da Costa L; Alves ADR; Pinto MA; Oliveira AC; Guedes HLM; Tanuri A; Castilho LR; Silva JL
iScience; 2021 Nov; 24(11):103315. PubMed ID: 34723156
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.
Barbier M; Lee KS; Vikharankar MS; Rajpathak SN; Kadam N; Wong TY; Russ BP; Cyphert HA; Miller OA; Rader NA; Cooper M; Kang J; Sen-Kilic E; Wong ZY; Winters MT; Bevere JR; Martinez I; Devarumath R; Shaligram US; Damron FH
Front Immunol; 2022; 13():948431. PubMed ID: 36091051
[TBL] [Abstract][Full Text] [Related]
8. Preparation and development of equine hyperimmune globulin F(ab')2 against severe acute respiratory syndrome coronavirus.
Lu JH; Guo ZM; Han WY; Wang GL; Zhang DM; Wang YF; Sun SY; Yang QH; Zheng HY; Wong BL; Zhong NS
Acta Pharmacol Sin; 2005 Dec; 26(12):1479-84. PubMed ID: 16297347
[TBL] [Abstract][Full Text] [Related]
9. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of Different Variants of SARS-CoV-2 by a F(ab')2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain.
Rodriguez-Nuñez M; Cepeda MDV; Bello C; Lopez MA; Sulbaran Y; Loureiro CL; Liprandi F; Jaspe RC; Pujol FH; Rangel HR
Antibodies (Basel); 2023 Dec; 12(4):. PubMed ID: 38131802
[TBL] [Abstract][Full Text] [Related]
11. Anti-SARS-CoV-2 equine F (Ab')
Botosso VF; Jorge SAC; Astray RM; de Sá Guimarães AM; Mathor MB; de Carneiro PDS; Durigon EL; Covas D; de Oliveira DBL; das Neves Oliveira R; Maria DA; Eto SF; Gallina NMF; Pidde G; Squaiella-Baptistão CC; Silva DT; Villas-Boas IM; Fernandes DC; Auada AVV; Banari AC; de Souza Filho AF; Bianconi C; de Agostini Utescher CL; Oliveira DCA; Mariano DOC; Barbosa FF; Rondon G; Kapronezai J; da Silva JG; Goldfeder MB; Comone P; Junior REC; Pereira TTS; Wen FH; Tambourgi DV; Chudzinski-Tavassi AM
Sci Rep; 2022 Mar; 12(1):3890. PubMed ID: 35273234
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS-CoV F(ab')(2) in macaque.
Xu Y; Jia Z; Zhou L; Wang L; Li J; Liang Y; Zhao T; Ni B; Wu Y
Int Immunopharmacol; 2007 Dec; 7(13):1834-40. PubMed ID: 17996696
[TBL] [Abstract][Full Text] [Related]
13. Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model.
Zhao Y; Wang C; Qiu B; Li C; Wang H; Jin H; Gai W; Zheng X; Wang T; Sun W; Yan F; Gao Y; Wang Q; Yan J; Chen L; Perlman S; Zhong N; Zhao J; Yang S; Xia X
Antiviral Res; 2017 Jan; 137():125-130. PubMed ID: 27890674
[TBL] [Abstract][Full Text] [Related]
14. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
Wang H; Wong G; Zhu W; He S; Zhao Y; Yan F; Rahim MN; Bi Y; Zhang Z; Cheng K; Jin H; Cao Z; Zheng X; Gai W; Bai J; Chen W; Zou Y; Gao Y; Gao GF; Yang S; Xia X; Qiu X
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541860
[TBL] [Abstract][Full Text] [Related]
15. Equine immunoglobulin F(ab')
Cui Z; Li D; Yi S; Guo Y; Dong G; Niu J; Zhao H; Zhang Y; Zhang S; Cao L; Wang K; Zhao Y; Hu G
Int Immunopharmacol; 2019 Oct; 75():105714. PubMed ID: 31352323
[TBL] [Abstract][Full Text] [Related]
16. Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection.
Cui J; Zhao Y; Wang H; Qiu B; Cao Z; Li Q; Zhang Y; Yan F; Jin H; Wang T; Sun W; Feng N; Gao Y; Sun J; Wang Y; Perlman S; Zhao J; Yang S; Xia X
Viruses; 2016 Dec; 8(12):. PubMed ID: 27999340
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.
Racine T; Denizot M; Pannetier D; Nguyen L; Pasquier A; Raoul H; Saluzzo JF; Kobinger G; Veas F; Herbreteau CH
J Infect Dis; 2019 Jun; 220(1):41-45. PubMed ID: 30852585
[TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.
Harvala H; Nguyen D; Simmonds P; Lamikanra AA; Tsang HP; Otter A; Maes P; Webster M; Clarkson A; Kaloyirou F; Hopkins V; Laidlaw SM; Carroll M; Mora A; Griffiths A; MacLennan S; Estcourt L; Roberts DJ
Transfusion; 2022 Jul; 62(7):1347-1354. PubMed ID: 35588314
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Efficacy of Equine Immunoglobulin F(ab')
Liu J; Zhang Z; Bai A; Sha Y; Ma L; Qin S; Chen F; Qin S; Wu J
Appl Biochem Biotechnol; 2021 Oct; 193(10):3151-3162. PubMed ID: 34086256
[TBL] [Abstract][Full Text] [Related]
20. Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab')2.
Zhao Z; Fan C; Duan Y; Zhang L; Li M; Yang X; Li R; Yang P; Wang X
Int Immunopharmacol; 2014 Nov; 23(1):134-8. PubMed ID: 25192652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
